SEC Form 4 · accession 0001179110-17-003856
Care.com Inc · CRCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Krupinski
Officer — Chief Technology Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412270
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Mar 1, 2017 | M | 4,000 | $6.02 | A | 182,635 | D | |
| Common Stock, $0.001 par valueF1,F2 | Mar 1, 2017 | S | 4,000 | $10.2006 | D | 178,635 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.02 | Mar 1, 2017 | M | 4,000 | D | — | Mar 1, 2023 | Common Stock | 4,000 | 72,000 | D |
| Restricted Stock UnitsF6,F4,F5 | — | Mar 1, 2017 | A | 8,706 | A | — | — | Common Stock | 8,706 | 8,706 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 12, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.18 to $10.26, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- F3The underlying shares subject to the option vest and become exercisable in successive, equal quarterly installments over four years measured from February 1, 2013, subject to the Reporting Persons continued service relationship with the Issuer on each such vesting date.
- F4Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F5The restricted stock units will vest as to 25% of the original grant on March 9, 2017. The balance of the grant will vest in twelve equal quarterly installments beginning on June 9, 2017. The restricted stock units have no expiration date.
- F6On March 11, 2016, the Reporting Person was granted an award of restricted stock units, which vest based upon the Issuer's satisfaction of certain performance goals. On March 1, 2017, the Audit Committee of the Issuer's Board of Directors determined that certain of the performance goals had been met, resulting in the vesting of these restricted stock units.